- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.2: 28 residues within 4Å:- Chain A: R.165, L.167, G.168, N.259, D.279, T.283, L.310, G.311, A.312, G.313, E.314, A.315, F.344, D.345, K.346, V.392, A.393, G.394, A.395, L.398, L.419, S.420, N.421, G.446, G.465, N.466, N.467
- Ligands: TTN.4
17 PLIP interactions:17 interactions with chain A- Hydrophobic interactions: A:T.283
- Hydrogen bonds: A:L.167, A:N.259, A:A.312, A:A.312, A:E.314, A:A.315, A:K.346, A:L.419, A:N.421, A:N.421, A:N.466, A:N.467, A:N.467
- Water bridges: A:G.313, A:A.316
- Salt bridges: A:R.165
NAD.3: 16 residues within 4Å:- Chain A: H.154, K.156, G.192, I.193, R.194, R.197, I.479, L.480, N.482, R.542, Y.552, R.556
- Chain D: N.153, D.244, R.245, G.247
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:H.154, A:G.192, A:R.194, A:Y.552, A:Y.552
- Salt bridges: A:R.542, A:R.556
- pi-Cation interactions: A:R.197
NAD.6: 27 residues within 4Å:- Chain B: R.165, L.167, G.168, N.259, D.279, T.283, L.310, G.311, A.312, G.313, E.314, A.315, F.344, D.345, K.346, V.392, A.393, G.394, A.395, L.419, S.420, N.421, G.446, G.465, N.466, N.467
- Ligands: TTN.8
14 PLIP interactions:14 interactions with chain B- Hydrophobic interactions: B:T.283
- Hydrogen bonds: B:L.167, B:N.259, B:A.312, B:A.312, B:E.314, B:E.314, B:A.315, B:K.346, B:L.419, B:N.421, B:N.421, B:N.467
- Salt bridges: B:R.165
NAD.7: 14 residues within 4Å:- Chain B: H.154, K.156, G.192, I.193, R.194, R.197, I.479, L.480, R.542, Y.552, R.556, W.558
- Chain C: D.244, R.245
12 PLIP interactions:11 interactions with chain B, 1 interactions with chain C- Hydrogen bonds: B:H.154, B:G.192, B:R.194, B:R.197, B:R.197, B:Y.552, B:Y.552, B:W.558
- Salt bridges: B:R.542, B:R.556, B:R.556
- Water bridges: C:G.247
NAD.10: 27 residues within 4Å:- Chain C: R.165, L.167, G.168, N.259, D.279, T.283, L.310, G.311, A.312, G.313, E.314, A.315, F.344, D.345, K.346, V.392, A.393, G.394, A.395, L.419, S.420, N.421, G.446, G.465, N.466, N.467
- Ligands: TTN.12
16 PLIP interactions:16 interactions with chain C- Hydrophobic interactions: C:T.283
- Hydrogen bonds: C:L.167, C:N.259, C:A.312, C:A.312, C:E.314, C:A.315, C:D.345, C:K.346, C:K.346, C:L.419, C:N.421, C:N.421, C:N.467
- Water bridges: C:G.313
- Salt bridges: C:R.165
NAD.11: 16 residues within 4Å:- Chain B: D.244, R.245, Y.246
- Chain C: H.154, K.156, G.192, I.193, R.194, R.197, I.479, L.480, N.482, R.542, Y.552, R.556, W.558
11 PLIP interactions:10 interactions with chain C, 1 interactions with chain B- Hydrogen bonds: C:G.192, C:R.194, C:R.197, C:N.482, C:Y.552, C:W.558, B:Y.246
- Salt bridges: C:R.542, C:R.556, C:R.556
- pi-Cation interactions: C:R.197
NAD.14: 28 residues within 4Å:- Chain D: R.165, L.167, G.168, N.259, D.279, T.283, L.310, G.311, A.312, G.313, E.314, A.315, F.344, D.345, K.346, V.392, A.393, G.394, A.395, L.398, L.419, S.420, N.421, G.446, G.465, N.466, N.467
- Ligands: TTN.16
17 PLIP interactions:17 interactions with chain D- Hydrophobic interactions: D:T.283
- Hydrogen bonds: D:R.165, D:L.167, D:N.259, D:A.312, D:A.312, D:E.314, D:A.315, D:D.345, D:K.346, D:L.419, D:N.421, D:N.421, D:N.467
- Water bridges: D:G.313, D:A.316
- Salt bridges: D:R.165
NAD.15: 16 residues within 4Å:- Chain A: N.153, D.244, R.245
- Chain D: H.154, K.156, G.192, I.193, R.194, R.197, I.479, L.480, N.482, R.542, Y.552, R.556, W.558
12 PLIP interactions:11 interactions with chain D, 1 interactions with chain A- Hydrogen bonds: D:H.154, D:G.192, D:R.194, D:R.197, D:Y.552, D:W.558
- Salt bridges: D:R.542, D:R.556, D:R.556
- pi-Cation interactions: D:R.197, D:R.197
- Water bridges: A:R.245
- 4 x TTN: TARTRONATE(Non-covalent)
TTN.4: 12 residues within 4Å:- Chain A: Y.112, R.165, L.167, K.183, E.255, D.256, D.279, N.421, N.466, N.467
- Ligands: MG.1, NAD.2
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:L.167, A:K.183, A:D.279, A:N.421, A:N.467
- Salt bridges: A:R.165, A:K.183
TTN.8: 11 residues within 4Å:- Chain B: Y.112, R.165, L.167, K.183, E.255, D.256, D.279, N.421, N.467
- Ligands: MG.5, NAD.6
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:K.183, B:E.255, B:D.256, B:D.279, B:N.421, B:N.467
- Salt bridges: B:R.165, B:K.183
TTN.12: 12 residues within 4Å:- Chain C: Y.112, R.165, L.167, K.183, E.255, D.256, D.279, N.421, N.466, N.467
- Ligands: MG.9, NAD.10
6 PLIP interactions:6 interactions with chain C- Hydrogen bonds: C:K.183, C:D.256, C:N.421, C:N.467
- Salt bridges: C:R.165, C:K.183
TTN.16: 11 residues within 4Å:- Chain D: Y.112, R.165, L.167, K.183, E.255, D.256, D.279, N.421, N.467
- Ligands: MG.13, NAD.14
6 PLIP interactions:6 interactions with chain D- Hydrogen bonds: D:K.183, D:E.255, D:N.421, D:N.467
- Salt bridges: D:R.165, D:K.183
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, Z. et al., Structure of a closed form of human malic enzyme and implications for catalytic mechanism. Nat.Struct.Biol. (2000)
- Release Date
- 2000-03-08
- Peptides
- MALIC ENZYME: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x TTN: TARTRONATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, Z. et al., Structure of a closed form of human malic enzyme and implications for catalytic mechanism. Nat.Struct.Biol. (2000)
- Release Date
- 2000-03-08
- Peptides
- MALIC ENZYME: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D